Clinical Trials on CNS

With an ever increasing average life expectancy, Neurological and CNS Disorders are becoming more prevalent in society. The economic and social costs of Neurological and CNS Disorders to society are huge. Many big pharmaceutical companies have moved away from CNS and Neurology research.

This meeting will give delegates an opportunity to gain additional knowledge and insights into the best practices in clinical trials, as well as addressing the challenges in CNS and Neurology research and by looking at the latest preclinical and clinical studies.

  • Clinical development in MS, PD and AD
  • Biomarkers implication in clinical trials
  • Current challenges in translational CNS research
  • Improvment of clinical trial development
  • Facilitating and establishing industry and academic partnering
  • Clinical trial safety and evaluation
  • New approaches for the design of clinical trials

Related Conference of Clinical Trials on CNS

Clinical Trials on CNS Conference Speakers